J Nephropathol. 2012;1(1): 23-30. doi: 10.5812/jnp.6
PMID: 24475383        PMCID: PMC3886167

Review Article

Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: A review on tacrolimus and cyclosporin in organ transplantation


Cited by CrossRef: 7


1- Fu R, Tajima S, Suetsugu K, Watanabe H, Egashira N, Masuda S. Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation. Acta Pharmacol Sin. 2019;40(2):151 [Crossref]
2- Sendra Gisbert L, Miguel Matas A, Sabater Ortí L, Herrero M, Sabater Olivas L, Montalvá Orón E, Frasson M, Abargues López R, López-Andújar R, García-Granero Ximénez E, Aliño Pellicer S. Efficacy of hydrodynamic interleukin 10 gene transfer in human liver segments with interest in transplantation. Liver Transpl. 2017;23(1):50 [Crossref]
3- Groll A, Townsend R, Desai A, Azie N, Jones M, Engelhardt M, Schmitt-Hoffman A, Brüggemann R. Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4. Transpl Infect Dis. 2017;19(5):e12751 [Crossref]
4- Meng L, Feng K, Ren Y. Molecular modelling studies of tricyclic triazinone analogues as potential PKC-θ inhibitors through combined QSAR, molecular docking and molecular dynamics simulations techniques. Journal of the Taiwan Institute of Chemical Engineers. 2018;91:155 [Crossref]
5- Zhang W, Egashira N, Masuda S. Recent Topics on The Mechanisms of Immunosuppressive Therapy-Related Neurotoxicities. IJMS. 2019;20(13):3210 [Crossref]
6- Fu K, DiNorcia J, Sher L, Velani S, Akhtar S, Kalayjian L, Sanossian N. Predictive Factors of Neurological Complications and One-Month Mortality after Liver Transplantation. Front Neurol. 2014;5 [Crossref]
7- Mencarelli A, Vacca M, Khameneh H, Acerbi E, Tay A, Zolezzi F, Poidinger M, Mortellaro A. Calcineurin B in CD4+ T Cells Prevents Autoimmune Colitis by Negatively Regulating the JAK/STAT Pathway. Front Immunol. 2018;9 [Crossref]